The human version of ANK-101 is currently undergoing Phase I clinical trials in the US and Canada. Credit: ...

With the new funding, Research Grid plans to invest in research and development, creating more AI automation and expanding its engineering teams. Credit: Collagery / Shutterstock. Research Grid has ...

Abbott has unveiled positive long-term data for its Esprit below-the-knee (BTK) stent in treating the most severe form of ...

The field of atopic dermatitis (AD) has been receiving great interest over the last few years with the approvals of both oral ...

The community screening programme charts an effective, affordable framework for TB control in the Canadian province of ...

Viking Therapeutics has announced its oral formulation of VK2735 has scored in a Phase I trial at ObesityWeek 2024.

Oak Hill Bio and Chiesi have enrolled the first European patient in a Phase IIb study for OHB-607, to prevent BPD in infants.

The world of clinical trials is undergoing a rapid change. Today, the rise of decentralized clinical trials (DCTs) and hybrid ...

The Phase III trial will investigate the Steriwave light-activated antimicrobial technology to reduce healthcare-associated infections. Image credit: Nicoleta Ionescu / Shutterstock. Ondine Biomedical ...

Sutro Biopharma has begun the REFRαME-P1 trial of Luvelta to treat paediatric patients with a type of acute myeloid leukaemia (AML).

The R3 Vascular investigational device exemption will be used to launch a pivotal trial of its treatment for peripheral arterial disease.

Endevica Bio has launched a new spin-off company, Abisati, to accelerate its obesity candidate into clinical trials.